https://orcid.org/0000-0002-2755-3700
References
- American College of Obstetricians and Gynecologists. Fetal growth restriction. Obstetrics gynecol practice bulletin No. 134. Obstet Gynecol. 2013;121(5):1122–1133.
- Sharma D, Shastri S, Farahbakhsh N, et al. Intrauterine growth restriction - part 1. J Matern Fetal Neonatal Med. 2016;29(24):3977–3987.
- Lausman A, Kingdom J, Gagnon R, et al. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can. 2013;35(8):741–748.
- Figueras F, Gratacos E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;36(2):86–98.
- Eroglu H, Turgal M, Senat A, et al. Maternal and fetal thiol/disulphide homeostasis in fetal growth restriction. J Maternal Fetal Neonat Med. 2019:1–8. doi: https://doi.org/10.1080/14767058.2019.1646239
- Gordijn SJ, Beune IM, Thilaganathan B, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333–339.
- Sharma D, Farahbakhsh N, Shastri S, et al. Intrauterine growth restriction – part 2. J Matern Fetal Neonatal Med. 2016;29(24):4037–4048.
- Krishna U, Bhalerao S. Placental insufficiency and fetal growth restriction. J Obstet Gynecol India. 2011;61(5):505–511.
- Balta S, Mikhailidis DP, Demirkol S, et al. Endocan: a novel inflammatory indicator in cardiovascular disease? Atherosclerosis. 2015;243(1):339–343.
- Yuksel MA, Tuten A, Oncul M, et al. Plasma endocan concentration in women with preeclampsia. Arch Gynecol Obstet. 2015;292(1):69–73.
- Hatfield KJ, Lassalle P, Leiva RA, et al. Plasma levels of endothelium-derived endokan are increased in patients with untreated acute myeloid leukemia. Hematology. 2011;16(6):351–356.
- Janke J, Engeli S, Gorzelniak K, et al. Adipose tissue and circulating endothelial cell specific molecule-1 in human obesity. Horm Metab Res. 2006;38(1):28–33.
- Adekola H, Romero R, Chaemsaithong P, et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med. 2015;28(14):1621–1632.
- Szpera-Gozdziewicz A, Kosicka K, Gozdziewicz T, et al. Maternal serum endocan concentration in pregnancies complicated by intrauterine growth restriction. Reprod Sci. 2019;26(3):370–376.
- Hadlock FP, Harrist RB, Sharman RS, et al. Estimation of fetal weight with the use of head, body, and femur measurements–a prospective study. Am J Obstet Gynecol. 1985;151(3):333–337.
- Audette MC, Kingdom JC. Screening for fetal growth restriction and placental insufficiency. Semin Fetal Neonatal Med. 2018;23(2):119–125.
- Mizuuchi M, Cindrova ‐Davies T, Olovsson M, et al. Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6β: implications for the pathophysiology of human pregnancy complications. J Pathol. 2016;238(4):550–561.
- Republic of Turkey Ministry of Health. Health Statistics Yearbook 2017. Ankara: Republic of Turkey Ministry of Health General Directorate of Health Information Systems; 2018.
- Khalil A, Thilaganathan B. Role of uteroplacental and fetal Doppler in identifying fetal growth restriction at term. Best Pract Res Clin Obstet Gynaecol. 2017;38:38–47.
- Watterberg KL, Aucott S, Benitz WE, et al. The Apgar Score. American Academy of Pediatrics Committee on Fetus and Newborn; American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Pediatrics. 2015;136(4):819–822.
- Royal College of Obstetricians & Gynaecologists. Small-for-gestational-age fetus, investigation and management (Green-top Guideline No:31) [Internet]. [cited 2019 Jun 17]. Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg31/.